Back
Corporate News
Natco Pharma's API unit in Mekaguda clears USFDA inspection
24-Jul-2025, 03:34
Natco Pharma announced that the U.S.FDA has issued Establishment Inspection Report (EIR) for the API facility located in Mekaguda on July 24 2025.
Natco Pharma announced that the U.S.FDA has issued Establishment Inspection Report (EIR) for the API facility located in Mekaguda on July 24 2025.
Powered by Capital Market - Live News